757 related articles for article (PubMed ID: 34731091)
1. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
Marston JL; Greenig M; Singh M; Bendall ML; Duarte RRR; Feschotte C; Iñiguez LP; Nixon DF
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34731091
[TBL] [Abstract][Full Text] [Related]
2. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
[TBL] [Abstract][Full Text] [Related]
3. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
Yang M; Li J; Deng S; Fan H; Peng Y; Ye G; Wang J; Wei J; Jiang X; Xu Z; Qing L; Wang F; Yang Y; Liu Y
Cells; 2022 Jan; 11(3):. PubMed ID: 35159296
[TBL] [Abstract][Full Text] [Related]
4. The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
Alsamman AM; Zayed H
PLoS One; 2020; 15(12):e0243270. PubMed ID: 33301474
[TBL] [Abstract][Full Text] [Related]
5. Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity.
Coden ME; Loffredo LF; Abdala-Valencia H; Berdnikovs S
Viruses; 2021 Jun; 13(6):. PubMed ID: 34198852
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses.
Cao Y; Xu X; Kitanovski S; Song L; Wang J; Hao P; Hoffmann D
Front Immunol; 2021; 12():656433. PubMed ID: 34122413
[TBL] [Abstract][Full Text] [Related]
7. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses.
Menachery VD; Eisfeld AJ; Schäfer A; Josset L; Sims AC; Proll S; Fan S; Li C; Neumann G; Tilton SC; Chang J; Gralinski LE; Long C; Green R; Williams CM; Weiss J; Matzke MM; Webb-Robertson BJ; Schepmoes AA; Shukla AK; Metz TO; Smith RD; Waters KM; Katze MG; Kawaoka Y; Baric RS
mBio; 2014 May; 5(3):e01174-14. PubMed ID: 24846384
[TBL] [Abstract][Full Text] [Related]
9. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells.
Yin Y; Liu XZ; He X; Zhou LQ
Front Cell Infect Microbiol; 2021; 11():609160. PubMed ID: 33732659
[TBL] [Abstract][Full Text] [Related]
10. Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages.
Grandi N; Erbì MC; Scognamiglio S; Tramontano E
Microbiol Spectr; 2023 Feb; 11(1):e0251622. PubMed ID: 36602345
[TBL] [Abstract][Full Text] [Related]
11. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
Jang Y; Seo SH
Arch Virol; 2020 Oct; 165(10):2205-2211. PubMed ID: 32651741
[TBL] [Abstract][Full Text] [Related]
12. Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract.
Dee K; Schultz V; Haney J; Bissett LA; Magill C; Murcia PR
J Infect Dis; 2023 Jun; 227(12):1396-1406. PubMed ID: 36550077
[TBL] [Abstract][Full Text] [Related]
13. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
14. Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2.
Gao KM; Derr AG; Guo Z; Nündel K; Marshak-Rothstein A; Finberg RW; Wang JP
JCI Insight; 2021 Nov; 6(22):. PubMed ID: 34618691
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
Front Immunol; 2021; 12():629193. PubMed ID: 33732251
[TBL] [Abstract][Full Text] [Related]
16. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
Zhou N; Bao J; Ning Y
BMC Bioinformatics; 2021 Jan; 22(1):18. PubMed ID: 33413085
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
[TBL] [Abstract][Full Text] [Related]
18. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
[TBL] [Abstract][Full Text] [Related]
20. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
